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Eighth
American Hepato Pancreato Biliary Congress
Annual Scientific Session and Postgraduate Course
March 27-30, 2008
Marriott’s Harbor Beach Resort & Spa
Ft. Lauderdale, Florida.
Wednesday March 26, 2008
1:00 pm Golf Tournament
7:00 pm Committee Meetings
Thursday March 27, 2008
7:00 am  9:30 am Executive Council Meeting
10:00 am  5:00 pm Postgraduate Course Emerging Technologies in Hepatobiliary
Disease
10:00 am  10:15 am Welcome and Opening Remarks
Mark P. Callery, MD, AHPBA President-Elect
Beth Israel Deaconess Medical Center, Harvard Medical School Boston, MA.
10:15 am  12:00 pm Session I: PANCREAS
Moderator: Roderich Schwarz, MD, Chair, Surgical Oncology, UT South-
western Medical Center, Dallas, TX.
10:15 am  10:30 am ‘‘The 2008 AHPBA/ASCO Consensus Conference on Pancreatic
Cancer’’
Speaker(s): Elijah Dixon, MD, University of Calgary, Alberta, Canada
Richard D. Schulick, MD, Johns Hopkins Medical Institutions, Baltimore, MD
10:30 am  10:45 am ‘‘Oncologic Adequacy of Emerging/Advanced Cancer Resection
Techniques’’
Speaker: Peter W.T. Pisters, MD, MD Anderson Cancer Center, Houston, TX.
10:45 am  11:00 am ‘‘Cyberknife Radiotherapy for Pancreatic Cancer’’
Speaker: Anand Mahadevan, MD, Beth Israel Deaconess Medical Center,
Boston, MA.
11:15 am  11:30 am ‘‘Tomorrow’s Approach to Chronic Pancreatitis’’
Speaker: David B. Adams, MD, Medical University of South Carolina,
Charleston, SC.
11:30 am  12:00 pm Pancreas Case Studies/ Panel Discussion
12:00 pm  1:00 pm Lunch
1:00 pm  2:15 pm Session II: LIVER TRANSPLANTATION
Moderator: Susan L. Orloff, MD, Professor, Department of Surgery, Oregon
Health & Science University, Portland VA Medical Center.
1:00 pm  1:15 pm ‘‘Donation after Cardiac Death (DCD) Transplants- Optimizing the
Value’’
Speaker: Scott R. Johnson, MD, Beth Israel Deaconess Medical Center, Boston,
MA.
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1:15 pm  1:30 pm ‘‘Live Donor Liver Transplantation- Indications, Outcomes and
Controversies’’
Speaker: Amadeo Marcos, MD, University of Pittsburgh Medical Center,
Pittsburgh, PA.
1:30 pm  1:45 pm ‘‘Deceased Donor Liver Transplantation  Appropriate Use of
Expanded Criteria Donors’’
Speaker: Sandy Feng, MD, University of Michigan, Ann Arbor, MI.
1:45 pm  2:00 pm ‘‘Hepatocellular Carcinoma  Values of Downstaging Prior to
Transplantation’’
Speaker: Will Chapman, MD, Washington University School of Medicine,
St Louis, MO.
2:00 pm  2:15 pm Liver Transplant Cases and Panel Discussion
2:15 pm  2:45 pm Session III: State of the Art Lecture
Introduction: Mark P. Callery, MD, AHPBA President- Elect.
‘‘NOTEStm in HPB Disease’’-
Speaker: Ram Chuttani, MD, Director of Endoscopy, Chief, Interventional
Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical
School.
2:45 pm  3:00 pm Coffee Break
3:00 pm  5:00 pm Session IV: HEPATOBILIARY
Moderators: N. Joseph Espat, MD, Roger Williams Medical Center, Providence
RI David A. Iannitti, MD, Carolinas Medical Center, Charlotte, NC.
3:00 pm  3:15 pm ‘‘Drug-Eluting Beads in the Treatment of Hepatic Malignancy’’
Speaker: Thomas Miner, MD, Brown University, Providence RI.
3:15 pm  3:30 pm ‘‘Are Microwaves Ready for Primetime in Liver Ablation’’
Speaker: David M. Lloyd, MBBS, Leicester Royal Infirmary, Leicester, UK.
3:30 pm  3:45 pm ‘‘Cyberknife RadioTherapy to Treat Primary and Metastatic Liver
Tumors’’
Speaker: Robert M. Goldstein, MD, Baylor Regional Transplant Institute,
Dallas, TX.
3:45 pm  4:00pm ‘‘Pre-transectional Radiofrequency Coagulation for Liver Resec-
tion’’
Speaker: Robert C. Martin, MD, University of Louisville, Louisville, KY.
4:00 pm  4:15 pm ‘‘Remaining Obstacles In Laparoscopic Liver Surgery’’
Speaker: David A. Geller, MD, University of Pittsburgh, Pittsburgh, PA.
***********************************************
12:00 pm  1:00 pm Fellows/Young Attendings Luncheon (By Invitation)
5:00 pm  7:00 pm Welcome Reception in the Exhibit Hall
7:00 pm  9:00 pm Sanofi-Aventis Dinner Symposium
‘‘Advances in the Management of Colorectal Liver Metastases: The Need for a
Multidisciplinary Approach’’.
7:00 pm  10:00 pm President’s Dinner (By Invitation)
Friday March 28, 2008
6:30 am  7:40 am Industry Sponsored Breakfast Symposium
R.F.A. Medical Solutions and Aloka Ultrasound, Bipolar Radiofrequency
Ablation, Speaker: Joseph Espat, M.D., Chief of Surgical Oncology, Roger
Williams Medical Center, Providence, RI.
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7:30 am  2:00 pm
and 6:30 pm7:30 pm Exhibits Open
7:45 am  9:30 am President’s Plenary Session-The highest rated abstracts in each
HPB discipline will be presented during this session (Abstracts 1-8)
1.) BRCA1 germline mutations as a cause of pancreatic cancer.
Wigdan Al-sukhni, MD, Heidi Rothenmund, MS, Ayelet Borgida, MS, George
Zogopoulos, MD, PhD, O’shea Anne Marie, MD, Steven Gallinger, MD, FRCP,
University of Toronto, Toronto, ON, Canada; Samuel Lunenfeld Research
Institute, Toronto, ON, Canada.
2.) Significance of AFPmRNA detected by real time PCR analysis
after curative hepatectomy for hepatocellular carcinoma.
Toshiya Kamiyama, MD, PhD, Kazuaki Nakanishi, MD, PhD, Hideki Yokoo,
MD, PhD, Munenori Tahara, MD, PhD, Tsuyoshi Shimamura, MD, PhD,
Hiroyuki Furukawa, MD, PhD, Michiaki Matsushita, MD, PhD, Satoru Todo,
MD, PhD, Hokkaido University, Sapporo, Japan.
3.) Intrahepatic Cholangiocarcinoma: Rising Incidence, Improved
Survival And Determinants Of Outcome After Resection.
Itaru Endo, MD, Mithat Gonen, Qin Zhou, Kimberly Moore Dalal, MD,
Michael D’angelica, MD, Ronald P. Dematteo, MD, Yuman Fong, MD,
Lawrence Schwartz, MD, Nancy Kemeny, MD, Leslie H. Blumgart, MD,
William R. Jarnagin, MD, Memorial Sloan-Kettering Cancer Center, New
York, NY.
4.) Clinical Response to Novel Dendritic Cell Based Vaccine
Strategy in Pancreatic Cancer Predicted by Biologic Factors.
Emmanuel E. Zervos, MD, James J. Mule, PhD, Nasreen Vohra, MD, Jennifer
Cooper, MS, William Janssen, PhD, Domenico Coppola, MD, Alexander
Rosemurgy, MD, East Carolina University, Greenville, NC; H. Lee Moffitt
Cancer Center and Research Institute, Tampa, FL; University of South Florida,
Tampa, FL; H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.
5.) Liver Cell Adenoma: A Multicenter Analysis of Risk Factors for
Rupture in 105 cases.
Jeremiah Deneve, DO, Timothy M Pawlik, MD, MPH, Steven Cunningham,
MD, Bryan M Clary, MD, Srinevas K Reddy, MD, Charles R. Scoggins, MD,
Robert C. G. Martin II, MD, Charles A Staley III, MD, David Kooby, MD,
Emory University, Atlanta, GA; Johns Hopkins, Baltimore, MD; Johns
Hopkins University, Baltimore, MD; Duke University, Durham, NC; University
of Louisville, Louisville, KY.
6.) Intention to treat survival following liver transplantation for
hepatocellular carcinoma within a donor service area.
Kevin P Charpentier, MD, Yee Lee Cheah, MD, Jason Machan, PhD, Thomas
Miner, MD, Paul Morrissey, MD, Anthony Monaco, MD, Rhode Island
Hospital, Providence, RI.
7.) Does Screening for Hepatocellular Cancer Affect Outcome?
Chet Hammill, MD, Linda L Wong, MD, University of Hawaii, Honolulu, HI;
Hawaii Medical Center-East, Honolulu, HI.
8.) Natural History and Surgical Treatment of Non-functional
Pancreatic Neuroendocrine Carcinoma: Population-based Analy-
sis.
Jan Franko, MD, PhD, Linwah W Yip, MD, Kenneth K Lee, MD, Alyssa M
Krasinskas, MD, Herbert J Zeh III, MD, David L Bartlett, MD, Arthur J
Moser, MD, University of Pittsburgh Medical Center, Pittsburgh, PA.
9:30 am  9:40 am Introduction of the President
Mark P. Callery, MD, President Elect, AHPBA, Beth Israel Deaconess Medical
Center, Boston, MA
9:40 am  10:10 am Presidential Address
Bruce D. Schirmer, MD, President, AHPBA, University of Virginia,
Charlottesville, VA, ‘‘HPB Training During Residency’’
10:10 am  10:30 am Coffee Break in the Exhibit Hall
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10:30 am  12:00 pm Laparoscopic Hepatobiliary Surgery: Who, What, When?
AHPBA/SAGES Combined Symposium
Moderators: David Ianitti and Will Chapman
Laparoscopic Liver Resection
The Case For: Joe Buell
The Case Against: Alan Hemming
Laparoscopic Donor Hepatectomy
The Case For: Alan Koffron
The Case Against: Paul Greig
Laparoscopic Pancreatectomy
The Case For: Michele Gagner
The Case Against: Mike Zenilman
Discussion: Is there a consensus?
What are the indications for laparoscopic liver and pancreatic resection? This
session will feature a balanced presentation of the advantages and potential
problems related to minimally invasive hepatic and pancreatic surgery. The
available data will be presented and the indications for minimally invasive
procedures will be debated.
10:30 am  12:00 pm Cholecystectomy Revisited. AHPBA/SSAT Combined Symposium
Moderators: Chuck Vollmer, Craig Fischer
Training Issues: John Hunter
The Difficult Gallbladder: Lygia Stewart
Biliary Injury During Cholecystectomy: Miguel Mercado
Diagnosis Cancer: Timothy Pawlik
Atypical Indications: James Toouli
A fresh look at an old problem. Issues related to surgery for gallbladder disease, the
most common hepatobiliary surgical procedure, will be discussed in depth.
12:00 pm  1:30 pm Lunch and Dessert with Exhibitors
1:30 pm  2:00 pm State of the Art Lecture  Pancreatic Resection for Ductal Adenocarci-
noma: Technical Considerations and Current State of the Art
Speaker: Masao Tanaka
Professor and Chairman, Department of Surgery and Oncology, Graduate School
of Medical Sciences, Kyushu University, Fukuoka, Japan.
State of the Art Lecture Transplantation for HCC: What are the limits?
Speaker: Goran Klintmalm
2:00 pm  2:30 pm President’s Invited Speaker
Current Topics in Health Care
Speaker: R. Scott Jones, M.D.
Professor and Chairman of Surgery Emeritus,
Department of Surgery, University of Virginia
Former President, American College of Surgeons, American Surgical
Association, Southern Surgical Association, and Society for Surgery of the
Alimentary Tract
Past Head, Division of Research and Optimal Patient Care, American College of
Surgeons
2:30 pm  2:45 pm Refreshment Break
2:45 pm  3:30 pm SPECIAL DEBATE 1-Management of Pancreatic Cystic Neoplasms
Moderator: Mark Callery
Radiology: Larry Schwartz
Debate: Murray Brennan vs. Keith Lillemoe
‘The risk of cancer is low for small lesions-close imaging follow-up and selective
resection is the best approach Murray Brennan
‘The cancer risk is high for all lesions-an aggressive policy of resection is therefore
warranted’ Keith Lillemoe
Rebuttal/Discussion
The management of pancreatic cystic neoplasms continues to evolve, and areas of
controversy remain. This session will feature a presentation of the relevant imaging
characteristics of these lesions, followed by a debate of management approaches for
this difficult clinical problem.
3:30 pm  4:15 pm SPECIAL DEBATE 2-Benign Liver Tumors: Changing Manage-
ment Paradigm?
Moderator: Nicholas Vauthey
Radiology: Vamsidha Narra
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Debate: David Geller vs. Yuman Fong
‘Close imaging follow-up is the best strategy in most patients with suspected benign
tumors’ Yuman Fong
‘Laparoscopic resection should be used more liberally in the management of
suspected benign tumors’ David Geller
Rebuttal/Discussion
Benign liver tumors are common and most require no intervention. However,
diagnostic uncertainty remains a major source of anxiety for both patient and
surgeon. In this regard, differentiating between hepatic adenoma and FNH and is
a frequent and particularly difficult problem. This debate will be centered around
the following question: Should hepatic resection be used more often in the
diagnostic algorithm of patients with suspected benign liver tumors, particularly as
minimally invasive hepatic resection techniques improve?
4:15 pm  5:30 pm Oral Poster Session
Oral Posters-Basic Science I
Abstract Numbers 918
9.) TIMP-3 Down-Regulates Hepatic mRNA Expression of Extra-
cellular Matrix Protein and Adhesion Molecules Genes in Ischemia/
Reperfusion Injury Animal Model: A RT-PCR Array Study
Ari J Cohen, MD, Zhen-ya Tang, MD, Ian Carmody, MD, O. Rama Swamy,
PhD, George Loss, MD, PhD, Ochsner Clinic Foundation, New Orleans, LA.
10.) Altered Aquaporin-9 (AQP9) expression and localization in
human hepatocellular carcinoma (HCC) and adjacent liver.
David A Iannitti Sr, MD, Peter Banks, MD, B. Todd Heniford, MD, Mollie
Palilonis, B.Sc., Amy Lincourt, PhD, Mark Russo, MD, MPH, Iain Mckillop,
PhD, Carolinas Medical Center, Charlotte, NC; University of North Carolina at
Charlotte, Charlotte, NC.
12.) The Expression of Interferon Receptor Alpha/Beta is Essential
for Tumor Response to Interferon Alpha Treatment in Human
Pancreatic Cancer Implanted in Nude Mice
Reza F. Saidi, MD, Ahmed Ahad, MD, Ilke Nalbantoglu, MD, Michael J
Jacobs, MD, Providence Hospital and Medical Centers, Southfield, MI; Wayne
State University, Detroit, MI.
13.) Cell death induced by an herb medicine pteris semipinnata L is
mainly involved in Bcl-2 family members in hepatocellular carci-
noma
George G Chen, MD, PhD, Nian-ci Liang, Ursula Pf Chan, Liao Cui, Taiping
He, Paul Bs Lai, The Chinese University of Hong Kong, Hong Kong, Hong
Kong; Guangdong Medical College,, Zhanjiang, Guangdong, China; Guang-
dong Medical College, Zhanjiang, Guangdong, China.
14.) Human Gallbladder Muscle Responds Synchronusly
Abhishek Mathur, MD, Hayder H Al-azzawi, MD, Kyle W Yancey, MD, Attila
Nakeeb, MD, Henry A Pitt, MD, Indiana University, Indianapolis, IN.
15.) Criteria for transfusion of fresh frozen plasma after hepatect-
omy for hepatocellular carcinoma
Yuki Kimura, MD, PhD, Kazuto Inoue, MD, PhD, Masamichi Moriguchi,
MD, PhD, Tadatoshi Takayama, MD, PhD, Nihon University, Tokyo, Japan.
16.) Development and validation of a reliable technique for intra-
operative sampling of pancreatic ductal juice during pancreatico-
duodenectomy for cancer.
Harsha R Hathurusinghe, MBBS, Melissa Cunha, None, Adrian Holt, Aali J
Sheen, MD, Ajith K Siriwardena, MD, Hepatobiliary Surgery Unit, Manchester
Royal Infirmary, Manchester, United Kingdom; Department of Clinical
Biochemistry, Manchester Royal Infirmary, Manchester, United Kingdom.
17.) Prophylactic Administration of Octreotide Continuous Infusion
to Prevent Pancreatic Anastomotic Fistula-A Pilot Study
Milton Lum, MD, Carmine M Volpe, MD, The Western Pennsylvania Hospital,
Pittsburgh, PA.
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18.) Intraoperative Fluorescence Imaging of Whole Pancreatico-
duodenal Transplant Allografts Using Indocyanine Green with
Laser Fluorescence: A Report of Two Cases
Edmund Q Sanchez, MD, Srinath Chinnakotla, MBBS, Dmitriy Nikitin, MD,
Tariq Khan, MD, Henry Randall, MD, Greg Mckenna, MD, Richard Ruiz,
MD, Nicholas Onaca, MD, Marlon Levy, MD, Robert Goldstein, MD, Goran
Klintmalm, MD, PhD, Baylor University Medical Center, Dallas, TX; Baylor
All Saints Medical Center, Fort Worth, TX.
Oral Posters-Biliary I
Abstract Numbers 1928
19.) Laparoscopic cholecystectomy in patients with liver cirrhosis
Jaikish Jayaraj, Subramanian M, SRI RAMACHANDRA MEDICAL
COLLEGE & RESEARCH INSTITUTE, Chennai -117, India.
20.) Voluntary And Involuntary Ligature Of The Bile Duct In
Iatrogenic Injuries: A Non Advisable Approach
Miguel-angel Mercado, MD, Carlos Chan, MD, Juan-carlos Jacinto, MD,
Norberto Sanchez, MD, Alexandra Barajas, MD, Instituto Nacional de la
Nutricio´n Salvador Zubira´n, Mexico City, Mexico.
21.) Surgical management of hilar cholangiocarcinoma: single
center experience
Yoshikazu Toyoki, Kenichi Hakamada, MD, PhD, Shunji Narumi, MD, PhD,
Masaki Nara, MD, PhD, Keinosuke Ishido, MD, PhD, Mutsuo Sasaki, MD,
PhD, Hirosaki University School of Medicine, Hirosaki, Japan.
22.) Endoscopic Management of Recurrent Primary Bile Duct
Stones
Geoffrey P Kohn, MBBS, A Sayed Hassen, MBBS, Simon W Banting,
MBBS, Sean Mackay, MBBS, Richard J Cade, MBBS, University of North
Carolina, Chapel Hill, NC; Box Hill Hospital, Melbourne, Australia.
23.) Strasberg D’’ Injury. Spectrum And Therapeutic Choices’’
Miguel-angel Mercado, MD, Carlos Chan, MD, Instituto Nacional de la
Nutricio´n Salvador Zubira´n, Mexico City, Mexico.
24.) Biliary Cancers: Initial Results From A Multidisciplinary HMO
Based Referral Center
Pascal R Fuchshuber, MD, PhD, Howard Young, MD, Paul Ho, MD, Sung
Cho, MD, Eugene Chan, MD, Ck Chang, MD, Kaiser Permanente Med.
Center, Walnut Creek, CA.
25.) A 14-Year Follow-Up Of Patients Observed In Two Rcts Of
Gallstone Disease: Pain Attacks Or Acute Cholecystitis
Karl Sondenaa, MD, PhD, Malte Schmidt, Morten Vetrhus, MD, PhD,
University of Bergen, Bergen N-5892, Norway; Stavanger University Hospital,
Stavanger N-4068, Norway.
26.) Establishing What Are ‘‘Normal’’ Values For Liver Function
Tests (Lfts) After Repair Of Biliary Injuries
Elizabeth A Fialkowski, MD, Emily R Winslow, MD, William G Hawkins,
MD, David C Linehan, MD, Steven M Strasberg, MD, Washington University
School of Medicine, Saint Louis, MO.
27.) Laparoscopic cholecystecomy using flexible gastroscope-the
first step on the way to NOTES
Yury Starkov, PhD, Kirill Shishin, Elena Solodinina, A.V.Vishnevsky Institute
of Surgery, Moscow, Russian Federation; A.V.Vishnevsky Instiyute of Surgery,
Moscow, Russian Federation.
28.) Totally laparoscopic choledochal cyst excision with Roux-en-Y
hepaticojejunostomy:Report of Eight cases.
Kee Hwan Kim, MD, Sang Kwon Lee, MD, Il Young Park, MD, Eung Guk
Kim, MD, Jeong Soo Kim, MD, Uijeongbu St. Mary’s Hospital, Catholic
University Medical College, Uijeongbu, Republic of Korea.
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Oral Posters  Liver I
Abstract Numbers 29  38
29.) Is Cirrhosis a contraindication to Laparoscopic Cholecystect-
omy-a single institution review
Sapna Bazaz, MBBS, Nicole Weimert, PharmD, David J. Taber, PharmD,
Kenneth D. Chavin, MD, PhD, Medical University of South Carolina,
Charleston, SC.
30.) Short-term outcome after splenectomy for treatment of
splenomegaly due to liver cirrhosis
Takao Tamesa, MD, PhD, Kazuhiko Sakamoto, MD, PhD, Yoshihiro Tokuhisa,
MD, Masaaki Oka, Department of Surgery &#8545;Yamaguchi University
Graduate School of Medicine, Ube, Japan.
31.) Staged liver procedures for colorectal metastases
Vladislav Treska, MD, MBA, Tomas Skalicky, MD, PhD, Alan Sutnar, MD,
Vaclav Liska, MD, JD, University Hospital, Plzen, Czech Republic.
32.) A Ten Year Prospective Audit of Liver Resection for Colorectal
Metastases in a Tertiary Referral Unit
Jeffrey T Lordan, MBBS, Nariman D Karanjia, MD, MBBS, Nial Quiney,
MBBS, William J Fawcett, MBBS, Tim R Worthington, MBBS, J Remington,
B.Sc., Royal Surrey County Hospital, Guildford, United Kingdom.
33.) A 10 year prospective study of outcome following hepatic
resection for colorectal liver metastases-The effect of evaluation in a
multi-disciplinary team setting.
Jeffrey T Lordan, MBBS, Nariman D Karanjia, MD, MBBS, Nial Quiney,
MBBS, William J Fawcett, MBBS, Tim R Worthington, MBBS, Jacky
Remington, B.Sc., Royal Surrey County Hospital, Guildford, United Kingdom.
34.) Laparoscopic Caudate Resection: A Difficult Approach
Ravi Nagubandi, MD, Mark Thomas, MD, Ravindra Kadiyala, MD, Amit
Tevar, MD, Steven Rudich, MD, Michael Marvin, MD, Joseph Buell, MD,
Jewish Hospital, University of Louisville, Louisville, KY, Louisville, KY;
University of Cincinnati, Cincinnati, OH; Jewish Hospital, University of
Louisville, Louisville, KY.
35.) Hand-Assisted Laparoscopic Liver Resections: A Learning
Curve
Justin H Nguyen, MD, Mayo Clinic, Jacksonville, FL.
36.) Surgical treatment of the benign liver lesions-a single centre
study.
Tomas Skalicky, MD, PhD, Vladislav Treska, MD, FRCP, University Hospital
Pilsen, Charles University Prague, Pilsen, Czech Republic.
37.) Symptomatic polycystic liver disease:Surgical management
and long-term quality of life outcomes
Robert T Russell, MD, Irene D Feurer, PhD, Panarut Wisawatapnimit, MS, C
Wright Pinson, MD, MBA, Vanderbilt University Medical Center, Nashville,
TN.
38.) Hepatic Resection in Canada from 19952004: Rate, Geographic
Variation, and Hospital Volumes
Ryan J Mccoll, MD, Xiaoqing You, Elijah Dixon, MD, University of Calgary,
Calgary, AB, Canada.
Oral Posters-Liver II
Abstract Numbers 39  48
39.) Suitability of patients with colorectal liver metastases for liver
resection: a cohort study
Thomas S Helling, MD, Sumesh Kaswan, MD, CONEMAUGH MEMOR-
IAL MEDICAL CENTER, Johnstown, PA.
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40.) A Case of Hepatic Artery Aneurysm in a Patient with Prune
Belly Syndrome.
Abdulelah M Alhawsawi, Michele Molinari, Dalhousie University, Halifax, NS,
Canada.
41.) Short-Term And Long-Term Results Of Laparoscopic Opera-
tions On The Liver At Non-Parasitic Cysts
Yury Starkov, PhD, Kirill Shishin, MD, Elena Solodinina, A.V.Vishnevsky
Institute of Surgery, Moscow, Russian Federation.
42.) Successful treatment for rib metastasis from hepatocellular
carcinoma
Yuki Kimura, MD, PhD, Masamichi Moriguchi, MD, Kazuto Inoue, MD,
PhD, Tadatoshi Takayama, MD, PhD, Nihon University, Tokyo, Japan.
43.) High serum alpha-fetoprotein level in patients with hepatocel-
lular carcinoma
Masamichi Moriguchi, MD, Yuki Kimura, MD, PhD, Kazuto Inoue, MD,
PhD, Tadatoshi Takayama, MD, PhD, Nihon University, Tokyo, Japan.
44.) Prototype of an online navigation system for laparoscopic RFA
Philipp Hildebrand, MD, Markus Kleemann, MD, Stefan Schlichting, Armin
Besirevic, Lutz Mirow, MD, Uwe Roblick, MD, PhD, Hans-peter Bruch, MD,
University of SChleswig-Holstein, Campus Lu¨beck, Lu¨beck, Germany; Uni-
versity of Schleswig-Holstein, Campus Lu¨beck, Lu¨beck, Germany.
45.) Treatment of Unresectable Hepatocellular Carcinoma with
Gemcitabine-based Transcatheter Arterial Chemoembolization
Jan Franko, MD, PhD, John S Hammond, MD, Shane E Holloway, MD,
Jason T Heckman, MD, Philip D Orons, DO, T. Clark Gamblin, MD,
University of Pittsburgh Medical Center, Pittsburgh, PA.
46.) Combined Hepatocellular Cholangiocarcinoma originating in a
background of Focal Nodular Hyperplasia: A Case Report and
Review of Literature
Eugene Lim, MBBS, Kenneth Mak, MBBS, Alexandra Hospital, Singapore,
Singapore.
47.) Results of Resection and Transplantation for HCCin Cirrhosis
and non-Cirrhosis
Fadi Rayya, MD, Michael Bartels, MD, Johann Hauss, MD, Josef Fangmann,
MD, University Hospital Leipzig, Leipzig, Germany.
48.) Transition from an open to a minimally invasive liver resection
practice:single center experience.
Alejandro Mejia, MD, Stephen Cheng, MD, Liver Institute at Methodist Dallas,
Dallas, TX.
Oral Posters  Pancreas I
Abstract Numbers 49  57
49.) Clinical epidemiological analysis of 309 ERCPs performed in
Nova Scotia in 2006 for choledocholithiasis and gallstone pancrea-
titis.
Michele Molinari, MD, Amy Nason, MS, Mark Joseph Walsh, Dalhousie
University, Halifax, NS, Canada.
50.) Extended Pancreatectomy With Resection Of The Celiac Axis
For Locally Advanced Cancer Of The Pancreatic Body. Surgical
Aspects Related With The Re-Arterialization Of The Liver And
Results
Emilio Vicente, MD, Yolanda Quijano, MD, Carmelo Loinaz, MD, Ramon D.
Conradi, MD, Manuel Marcello, MD, Pablo Galindo, MD, Enrique Esteban,
MD, Fernando Lapuente, MD, Rafael Alvarez, MD, Luis Cordoba, MD, Raul
Macedo, MD, Hospital Madrid Norte Sanchinarro, Madrid, Spain.
51.) Pancreatic Tuberculosis-A Rare Dual Presentation
Jaikish Jayaraj, Subramanian M, SRMC & RI, Chennai, India.
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52.) The Whip-Stow Procedure: An innovative modification to the
Whipple Procedure.
Christos A Galanopoulos, MD, D Rohan Jeyarajah, MD, Methodist Dallas
Medical Center, Dallas, TX.
53.) Conservative Treatment In Pancreatic Pseudocyst In Children
Paraian Ioan, MD, PhD, Budusan Anca, Ordeanu Calin, PhD, University of
Medicine and Pharmacy, Cluj-napoca, Romania; Children‘s Hospital, Cluj-
napoca, Romania.
54.) Laparoscopic Distal Pancreatectomy-Splenectomy for a Der-
moid Cyst of the Pancreas-Case Report and Review of the
Literature
John George Zografakis, MD, Steven Wanek, MD, Adrian George Dan, MD,
Summa Health System, Akron, OH.
55.) Surgical Management of Locally Advanced Pancreatic and
Peripancreatic Neoplasms Involving Major Visceral Arteries
Trina Steljes, MD, Jose Almeda, MD, Gagandeep Singh, MD, Linda Sher, MD,
Maria Stapfer, MD, Rodrigo Mateo, MD, Rick Selby, MD, Yuri Genyk, MD,
Keck School of Medicine, University of Southern California, Los Angeles, CA.
56.) Total Pancreatectomy for Nesidioblastosis: How far should you
go?
Carla Fisher, MD, Katherine Morgan, MD, David Adams, MD, Medical
University of South Carolina, Charleston, SC.
57.) A novel use of the Harmonic ACE during Pancreaticoduode-
nectomy with no post-operative bleeding.
Christos A. Galanopoulos, MD, Allison Vo, RN, D. Rohan Jeyarajah, MD,
Methodist Dallas Medical Center, Dallas, TX.
Oral Posters  Pancreas II
Abstract Numbers 59  67
59.) Surgical Management of panreatic and peri- ampullary
carcinoma by Kausch-Whipple or Watson-Traverso-a controlled
randomised long term single centre trial
Karl J Paquet, MD, Clinic Werlich-Barie´ Bad Kissingen, Bad Kissingen,
Germany.
60.) Variant Visceral Arterial Anatomy and Pancreaticoduodenect-
omy (PD): Incidence, Recognition, and Management
John Stauffer, MD, Naciye Turan, MD, Mellena Bridges, MD, Justin H
Nguyen, MD, J. Kirk Martin, MD, Mayo Clinic, Jacksonville, FL.
61.) Use Of Ptfe For Portal Vein Reconstruction During Pancrea-
ticoduodenectomy
John Andrew Stauffer, MD, Marjorie K Dougherty, PA-C, MPH, Denise M
Harnois, DO, George P Kim, MD, Justin H Nguyen, MD, Mayo Clinic,
Jacksonville, FL.
62.) Accuracy of Magnetic Resonance Imaging in assessing local
resectability of pancreatic cancer.
Marc Sarti, MD, Reid B. Adams, MD, S. Lowell Kahn, MD, Todd W. Bauer,
MD, Eduard E. De Lange, MD, University of Virginia, Charlottesville, VA.
63.) Evidence in favour of standardization of indications for
operative intervention in painful chronic pancreatitis.
Nehal Shah, Ajith K Siriwardena, Hepatobiliary Surgery Unit, Manchester
Royal Infirmary, Manchester, United Kingdom.
64.) Accuracy of CT in Predicting Malignant Potential of Cystic
Pancreatic Neoplasms
William E. Fisher, MD, Sally E. Hodges, Vivek Yagnik, MD, Fannie E. Moro´n,
MD, Meng Fen Wu, MS, Susan G. Hilsenbeck, PhD, Isaac L. Raijman, MD, F.
Charles Brunicardi, MD, Elkins Pancreas Center, Dan L. Duncan Cancer
Center, Michael E. DeBakey Department of Surgery, Baylor College of Medicine,
Houston, TX.
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65.) Laparoscopic Distal Pancreatectomy for Pancreatic Adeno-
carcinoma: Is An Appropriate Oncologic Resection Possible?
James E. Fisher, MD, Michael L Kendrick, MD, Mayo Clinic, Rochester, MN.
66.) Comparative outcome of the retroperitoneal, endoscopic and
laparoscopic approaches to minimally invasive necrosectomy.
Benoy Idicula Babu, MBBS, A.k Siriwardena, MD, MANCHESTER ROYAL
INFIRMARY, Manchester, United Kingdom.
67.) Middle Pancreatectomy Is A Technique Readily Incorporated
Into A Pancreatic Surgeon’s Clinical Practice
Harish Lavu, MD, Jamie L Knuth, Marshall S Baker, MD, Nicholas J
Zyromski, MD, C Max Schmidt, MD, PhD, Attila Nakeeb, MD, Thomas J
Howard, MD, Department of Surgery, Indiana University School of Medicine,
Indianapolis, IN.
Oral Posters-Transplant
Abstract Numbers 68  77
68.) Recurrent liver abscesses secondary to the use of pledgets after
penetrating liver trauma
Angel M Morales, MD, Steve H. Dougherty, MD, Texas Tech Health Sciences
Center at El Paso, El Paso, TX.
69.) Role of Intraarterial Infusion Chemotherapy With Prostaglan-
din E1 For Hcc Patient With Type C Cirrhosis
Shinji Uchida, MD, Masanori Akashi, MD, Kurume University, Kurume,
Japan.
70.) A Ten Year Prospective Study Comparing Right and Extended
Right Hepatectomies with All Other Liver Resections for Colorectal
Metastases.
Jeffrey T Lordan, MBBS, Nariman D Karanjia, MD, MBBS, Nial Quiney,
MBBS, William J Fawcett, MBBS, Tim R Worthington, MBBS, Jacky
Remington, B.Sc., Royal Surrey County Hospital, Guildford, United Kingdom.
71.) Patients’ Economic impact of orthotopic liver transplant in
Atlantic Canada
Michele Molinari, MD, Amy Gillis, MD, Mark Joseph W, MD, Dalhousie
University, Halifax, NS, Canada.
72.) Surgical Vascular Procedures For Malignancies With Inferior
Vena Cava Involvement
Emilio Vicente, MD, Yolanda Quijano, MD, Carmelo Loinaz, MD, Ramon D.
Conradi, MD, Manuel Marcello, MD, Pablo Galindo, MD, Enrique Esteban,
MD, Fernando Lapuente, MD, Rafael Alvarez, MD, Luis Cordoba, MD, Raul
Macedo, MD, Hospital Madrid Norte Sanchinarro, Madrid, Spain.
73.) Living Donor Liver Transplantation: Post-Operative Imaging
Follow-up of 54 Right Lobe Donors with Clinical Correlation
Suzanne Palmer, MD, Lusine Tumyan, MD, Eric Huang, Linda Sher, MD,
Yuri Genyk, MD, University of Southern California, Los Angeles, CA.
74.) A Prospective Study Of Abdominal Pain And Functional
Symptoms In Living Liver Donors After Partial Liver Donation And
Gallbladder Removal
Karl Sondenaa, MD, PhD, Gabriel Gondolesi, MD, Sasan Roayaie, MD,
Sukru Emre, MD, Jody S. Goldman, RN, Trygve Hausken, MD, Myron E.
Schwartz, MD, University of Bergen, Bergen, N-5892, Norway; Adult Liver
Transplantation & Hepatobiliary Surgery and Recanati/Miller Transplantation
Institute, Mount Sinai Medical Center, New York, NY; University of Bergen,
Bergen, N-5020, Norway.
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75.) Intraoperative Fluorescence Imaging of Liver Transplant
Allografts Using Indocyanine Green with Laser Fluorescence: A
Report of 5 Cases.
Edmund Q Sanchez, MD, Srinath Chinnakotla, MBBS, Dmitriy Nikitin, MD,
Tariq Khan, MD, Sugam Vasani, MD, Henry Randall, MD, Greg Mckenna,
MD, Richard Ruiz, MD, Nicholas Onaca, MD, Marlon Levy, MD, Robert
Goldstein, MD, Goran Klintmalm, MD, PhD, Baylor University Medical
Center, Dallas, TX; Baylor All Saints Medical Center, Fort Worth, TX.
76.) Bariatric surgery and liver transplantation: single center
experience with six cases
Hugo Bonatti, MD, Jennifer Slocum, RN, CNP, Rolland C Dickson, MD, John
Stauffer, MD, Denise Harnois, DO, Justin Nguyen, MD, Jaime Aranda-michel,
MD, UVA, Charlottesville, VA; Mayo Clinic, Jacksonville, FL.
77.) Surgical Site Infections Rates After Pancreaticoduodenectomy
are Decreased with the use of a Wound Edge Protector
Jayme B. Stokes, MD, Brian R. Swenson, MD, Todd W. Bauer, MD, Reid B.
Adams, MD, University of Virginia, Charlottesville, VA.
5:30 pm  6:00 pm Business Meeting
2007 Research Fellowship Award Presentation and
2006 Research Updates
6:30 pm  7:30 pm Cocktail Reception in the Exhibit Hall
7:30 pm  10:00 pm Congress Banquet
Saturday March 29, 2008
6:30 am  7:40 am Industry Sponsored Breakfast Symposium
Aloka Ultrasound, Minimally Invasive Liver Surgery
Speaker: T. Clark Gamblin, M.D., Assistant Professor of Surgery, Division of
Surgical Oncology, Division of Transplantation, UPMC Liver Cancer Center,
Pittsburgh, PA
Industry Sponsored Breakfast Symposium
Pathfinder Therapeutics, Inc., Clinical Experience with Image-Guided
Liver Surgery
Speaker: David Geller, M.D.
Industry Sponsored Breakfast Symposium
Globex & PIM, Current Trends and Practice Guidelines for the Treatment of
Intra-Abdominal Infections
Med Ed Company: Global Education Exchange, Inc., Globex
CME Provider: Postgraduate Institute for Medicine, PIM
Commercial Supporter: Merck, Inc.
Speaker: Philip S. Barie, M.D., and Samuel E. Wilson, M.D.
7:30 am  2:00 pm &
6:30 pm  7:30 pm Exhibits Open
7:45 am  9:45 am Free Paper Session: Liver (Abstracts 78 to 86)
78.) Laparoscopic Resection of Hepatic Tumors in Cirrhotics
Ravi Nagubandi, MD, Mark Thomas, MD, Ravindra Kadiyala, MD, Amit
Tevar, MD, Steven Rudich, MD, Michael Marvin, MD, Joseph Buell, MD,
Jewish Hospital Transplant Center, University of Louisville, Louisville, KY;
University of Cincinnati, Cincinnati, OH.
79.) Ablation vs. Resection for Hepatic Colorectal Metastasis:
Therapeutically Equivalent?
Nathaniel P Reuter, MD, Charles E Woodall III, MD, Charles R Scoggins, MD,
Kelly M Mcmasters, Robert C Martin II, MD, University of Louisville,
Louisville, KY.
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80.) Preoperative Predictors Of Outcome After Hepatic Resection
Of Colorectal Metastases In Patients Treated With Preoperative
Chemotherapy
Yoji Kishi, MD, Dan G Blazer, MD, Daria Zorzi, MD, Joshua M Mammen,
MD, Eduardo Palavecino, MD, Yun Shin Chun, MD, Steven Curley, MD,
Eddie Abdalla, MD, Jean-nicholas Vauthey, MD, M.D. Anderson Cancer
Center, University of Texas, Houston, TX.
81.) Improving Glycogen Liver Content Improves Postoperative
Liver Function in Patients Undergoing Major Liver Resections
M Hassanain, MD, R Lattermann, MD, G Carvalho, MD, H Karasek, B.Sc.,
H Molla, B.Sc., S Paglialunga, B.Sc., A Khankan, MBBS, D Valenti, MD, D
Vrochides, MD, P Chaudhuary, MD, T Schricker, MD, P Metrakos, MD,
McGill University, Montreal, PQ, Canada.
82.) The MELD Based Objective Scoring System (MOSS): New
Insights into Risk Stratification of Cirrhotic Patients with Hepato-
cellular Carcinoma
Swee H Teh, MD, Susan L Orloff, MD, Brett C Sheppard, MD, Jonathan
Schwartz, MD, John Kaufman, MD, Stephen Cha, PhD, Ray W Kim, MD,
Patrick S Kamath, MD, David M Nagorney, MD, Oregon Health Sciences
University, Portland, OR; Mayo Clinic, Rochester, MN.
83.) Yttrium-90 Intra-Arterial Brachytherapy for Unresectable
Hepatocellular Cancer with Portal Vein or IVC Thrombosis: Safe
and Clinically Beneficial?
Charles E Woodall III, MD, Charles R. Scoggins, MD, Susan F. Ellis, Clifton
M. Tatum Jr., MD, Michael J. Hahl, MD, James N Hiken, MD, Brain C.
Jones, MD, Kelly M. Mcmasters, MD, Robert C.g. Martin II, MD, University
of Louisville, Louisville, KY; Norton Hospital, Louisville, KY.
84.) Laparoscopic Versus Open Liver Resection For Hepatocellular
Carcinoma: A Comparative Study
Ibrahim Dagher, MD, PhD, Caroline Famechon, MD, Panagiotis Lainas, MD,
Jose G Tralhao, MD, PhD, Helene Agostini, MD, Dominique Franco, MD,
PhD, Antoine Beclere Hospital, Clamart, France.
85.) The Impact of Aggressive Treatment of Chronic Colorectal
Cancer Liver Metastases on Quality of Life
Gabriel Chan, MD, Mazen Hasssanain, MBBS, Nicolas Meti, Amy Neville,
MD, Prosanto Chaudhury, MD, Peter Metrakos, MD, McGill University,
Montreal, PQ, Canada.
86.) Major Hepatic Resection for Hepatocellular Carcinoma with or
without Portal Vein Embolization: Perioperative Outcome and
Survival
Martin Palavecino, MD, Joshua M V Mammen, MD, Yun S Chun, MD, Daria
Zorzi, MD, Yoji Kishi, MD, Steven H Wei, PA-C, MPH, Manal M Hassan,
MD, Melanie B Thomas, MD, Steven A Curley, MD, Eddie K Abdalla, MD,
Jean N Vauthey, MD, MD Anderson Cancer Center, Houston, TX.
7:45 am  9:45 am Free Paper Session: Basic Science (Abstracts 87 to 95)
87.) Angiotensin II induces Vascular Endothelial Growth Factor in
Pancreatic Cancer Cells
Hwyda A. Arafat, MD, PhD, Galina Chipitsyna, PhD, Qioake Gong, MD,
Rathai Anandanadesan, MD, Charles J. Yeo, MD, Thomas Jefferson Univesity,
Philadelphia, PA.
88.) MicroRNA-21 is Overexpressed in Pancreatic Cancer and a
Potential Predictor of Survival
Mary Dillhoff, MD, Wendy L Frankel, MD, James Liu, MD, Mark Bloomston,
MD, Ohio State University, Columbus, OH.
89.) Hepatic Interferon Regulatory Factor-1 Expression During
Liver Ischemia Reperfusion Injury is TLR-4 Dependent
Jon S Cardinal, MD, Rajeev Dhupar, MD, Geetha Jeyabalan, MD, Allan
Tsung, MD, David Geller, MD, University of Pittsburgh Medical Center,
Pittsburgh, PA.
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90.) Differential expression of pro-inflammatory cytokines and
EMC remodeling enzymes by ED2dim hepatic macrophages versus
ED2high Kupffer cells in rat livers
Gordon D Wu, MD, Yao He, MD, PhD, Andrew S Klein, MD, Cedars-Sinai
Medical Center, Los Angeles, CA.
91.) TLR4 signaling causes increased damage to steatotic livers after
ischemia/reperfusion injury
Justin D Ellett, B.Sc., Zachary P Evans, PhD, Michael G Schmidt, PhD,
Kenneth D Chavin, MD, PhD, Medical University of South Carolina,
Charleston, SC.
92.) Exploration of anti-VEGF Mechanisms in Experimental
Pancreatic Cancer
Niranjan Awasthi, PhD, Margaret Schwarz, MD, Srivani Konduri, PhD,
Varun Verma, MS, Clint Capiello, MS, Roderich E Schwarz, MD, UT
Southwestern Medical Center, Dallas, TX; UMDNJ-Robert Wood Johnson
Medical School, New Brunswick, NJ.
93.) Focal adhesion kinase (FAK) regulates the metastatic pheno-
type of gastrointestinal carcinoid cancer cells through the Raf-1
signaling pathway
Li Ning, MD, Muthusamy Kunnimalaiyaan, PhD, Herbert Chen, MD,
University of Wisconsin, Madison, WI.
94.) Combined TRAIL and HSP70-inhibition therapy induces
apoptosis synergistically in human pancreatic cancer cells
Daniel Borja-cacho, MD, Pawel Zwolak, MD, Vikas Dudeja, MD, Selwyn M
Vickers, MD, Ashok K Saluja, PhD, University of Minnesota, Minneapolis,
MN.
95.) Suppression of Pancreatic Carcinoid Tumor Cell Growth and
Neuroendocrine Hormone Production by Akt-1 Inhibition
Susan C Pitt, MD, Herbert Chen, MD, Muthusamy Kunnimalaiyaan, PhD,
Endocrine Surgery Research Laboratories, University of Wisconsin, Madison,
WI.
9:45 am  10:15 am State of the Art Lecture  Liver Surgery in the Cirrhotic Patient
Speaker: Dave Nagorney
10:15 am  10:30 am Coffee Break in the Exhibit Hall
10:30 am  12:30 pm Transplantation for HCV
Moderators: Susan Orloff and Doug Hanto
Screening for HCC: What Is The Standard? Nid Afdhal
Downstaging HCC prior to Transplantation-Francis Yao
Recurrent HCV Following OLT: Who Should be Treated? James Burton
Retransplantation for HCV: Should This Ever Be Done? Sasan Royaie
Liver transplantation in patients with chronic hepatitis C is associated with a
unique set of problems. This symposium will review the most recent data in the field
in order to provide guidance in the management of this difficult clinical problem.
10:30 am  12:30 pm Free Papers Session: Pancreas (Abstracts 96 to 104)
96.) A Comparison of Pancreaticoduodenectomy and Duodenal
Sparing Head Resection for the Treatment of Chronic Pancreatitis
Rebecca J Mcclaine, MD, Andrew M Lowy, MD, Andres Gelrud, MD, Nathan
Schmulewitz, MD, Shailendra Chauhan, MD, Laura E James, MS, Jeffrey J
Sussman, MD, Jeffrey B Matthews, MD, Syed A Ahmad, MD, University of
Cincinnati, Cincinnati, OH; University of California, San Diego, La Jolla, CA;
University of Chicago, Chicago, IL.
97.) Fungal Infection In Necrotizing Pancreatitis Causes A Dra-
matic Rise In Morbidity And Mortality.
Yuriy Zhukov, Thomas J Howard, MD, Lee Mchenry, MD, Evan L Fogel, MD,
Attila Nakeeb, MD, Henry A Pitt, MD, Keith D Lillemoe, MD, Christian M
Schmidt, MD, Nicholas J. Zyromski, MD, Indiana University School of
Medicine, Department of Surgery, Indianapolis, IN.
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98.) Determining Pattern of Recurrence following Pancreatico-
duodenectomy: Effect of Lymph Node Ratio and Number of Positive
Nodes
Bolanle Asiyanbola, MD, Joseph Herman, MD, Ana Gleisner, MD, Michael
Choti, MD, Christopher Wolfgang, MD, PhD, Richard Schulick, MD, John
Cameron, MD, Timothy M Pawlik, MD, Johns Hopkins, Baltimore, MD.
99.) The Latent Presentation of Pancreatic Fistulae
Wande Pratt, Mark Callery, MD, Charles Vollmer, MD, Beth Israel Deaconess
Medical Center, Boston, MA.
100.) Survival After Pancreaticoduodenectomy Is Not Improved By
Extending Resections To Achieve Negative Margins
Jonathan M Hernandez, MD, Desiree Villadolid, MPH, Paul Toomey, B.Sc.,
John Mullinax, MD, C Whalen Clark, MD, Lorraine Tomlinson, None, Steven
Goldin, MD, PhD, Alexander Rosemurgy, MD, University of South Florida
College of Medicine Department of Surgery, Tampa, FL.
101.) Presence of Symptoms, Tumor Size, and Imaging Character-
istics do not Reliably Predict Malignancy in Mucinous Cystic
Neoplasms of the Pancreas
Jayme B. Stokes, MD, Edward B. Stelow, MD, Marc Sarti, MD, Eduard E. De
Lange, MD, Reid B. Adams, MD, Todd W. Bauer, MD, University of Virginia,
Charlottesville, VA.
102.) Cyberknife Radiosurgery for Pancreatic Cancer
Anand Mahadevan, Michael Goldstein, Sanjay Jain, Mark Callery, Charles
Vollmer, BethIsrael Deaconess Medical center, Boston, MA.
103.) Antibacterial Prophylaxis Does Prevent Death From Acute
Necrotising Pancreatitis, But Not By Preventing Infection Of
Pancreatic Necrosis
Eduardo A Villatoro, MD, Mubashir Mulla, MD, Richard I Hall, MD, MBBS,
Michael Larvin, MD, MBBS, University of Nottingham at Derby, Derby,
United Kingdom; Derby Hospitals NHS Foundation Trust, Derby, United
Kingdom.
104.) A Genetic Expression Profile of Chemoresistant Pancreatic
Cancer
Anthony Razzak, B.Sc., Abdul Saeid, MD, Jose Trevino, MD, Justin Hering,
MD, Joseph Espat, MD, Roger Williams Cancer Center, Providence, RI.
12:30 pm  1:30 pm Lunch
1:30 pm  2:45 pm Emerging Therapies for HCC
Moderators: Myron Schwartz and Elijah Dixon
Systemic Chemotherapy  Josep Llovet
Regional Chemotherapy: Yttrium-90 Microspheres  Raid Salem
Radiofrequency Ablation of Small HCC  Allen Siperstein
Parenchymal Sparing Resection  Michael D’Angelica
Molecular Profiling of HCC  Wallis Marsh
Hepatocellular carcinoma remains one of the leading causes of cancer-related
death around the world. This symposium brings together several experts to discuss
therapeutic advances and the current state of the art in molecular profiling.
1:30 pm  2:45 pm State of the Art Imaging in HPB Diseases
Moderators: Larry Schwartz and Roderich Schwarz
Imaging Primary Malignancies of the Liver  Vamsidha Narra
Imaging the IPMN Spectrum  Lawrence Schwartz
Molecular Imaging in Hepatobiliary Disease  Timothy Akhurst
Monitoring Response to Local Therapies  David Grand
Improvements in imaging continue at a rapid rate and profoundly influence the
practice of HPB surgery. This session highlights advances in imaging for primary
liver cancer and pancreatic IPMN and will additionally feature a discussion of the
emerging data in molecular imaging and novel methods for monitoring tumor
treatment response.
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2:45 pm  4:45 pm Free Papers: Transplant (Abstracts 105 to 113)
105.) Outcomes Using Grafts From Donation After Cardiac Death
Donors: Preliminary Results
M. B. Majella Doyle, MD, Neeta Vachharajani, MD, Christopher D. Anderson,
MD, Jason R. Wellen, MD, Jeffrey A. Lowell, MD, William C. Chapman, MD,
Washington Universtiy, St Louis, MO.
106.) Simultaneous Pancreatectomy and Liver Transplantation: A
Single Institution Experience
Rajeev Dhupar, MD, J. Wallis Marsh, MD, Paulo A Fontes, MD, Michael E
Devera, MD, Jennifer L Steel, PhD, Herbert Zeh, MD, David A Geller, MD,
Amadeo Marcos, MD, T. Clark Gamblin, MD, University of Pittsburgh,
Pittsburgh, PA.
107.) A Safe Approach For The Use Of Liver Allografts From
Hepatitis B Core Antibody- Positive Donors.
Sameh Adel Fayek, MD, Timothy D. Siropaides, Oren Shaked, Kim M. Olthoff,
MD, K. Rajender Reddy, MD, University of Pennsylvania Hospital, Philadel-
phia, PA.
108.) Advanced Donor Age Does Not Affect Patient or Graft
Survival Following Liver Transplantation
Christopher D Anderson, MD, Neeta Vachharajani, M. B. Majella Doyle, MD,
Jason R. Wellen, MD, Surendra Shenoy, MD, Jeffrey A Lowell, MD, William C
Chapman, MD, Washington University in St Louis, St Louis, MO; Washington
University in St Louis, St. Louis, MO.
109.) Hepatic blood flow predicts allograft and patient survival
following liver transplantation.
Austin L. Spitzer, MD, Andre A. Dick, MD, Ramasamy Bakthavatsalam, MD,
Jeffrey B. Halldorson, MD, Adam Levy, MD, Jorge D. Reyes, MD, James D.
Perkins, MD, University of Washington, Seattle, WA.
110.) Surgical Portosystemic Shunts for Potral Hypertension in the
Era of Orthotopic Liver Transplantation: The Role of the Splenor-
enal Interposition H-Graft
Robert R Slater, MD, Atsushi Yoshida, MD, Dean Y Kim, MD, Marwan
Abouljoud, MD, Henry Ford Hospital, Detroit, MI.
111.) Autologous Islet Transplantation Combined With Total
Pancreatectomy
Sonal Asthana, MD, Tatsuya Kin, PhD, Norman Kneteman, MD, Andrew M J
Shapiro, MD, PhD, David L Bigam, MD, University of Alberta Hospital,
Edmonton, AB, Canada.
112.) Does base line body mass index influence short and long term
outcome after liver transplantation
Jaime Aranda-michel, MD, Hugo Bonatti, MD, Rolland C Dickson, MD, John
Stauffer, MD, Denise Harnois, DO, Justin Nguyen, MD, Mayo Clinic,
Jacksonville, FL; UVA, Charlottesville, VA.
113.) Outcomes And Trends In Liver Transplantation As Reported
In The Srtr Registry
Hussein Saad, B.Sc., Atsushi Yoshida, MD, Dean Kim, MD, Marwan S.
Abouljoud, MD, Henry Ford Hospital, Detroit, MI.
2:45 pm  4:45 pm Free Papers: Biliary (Abstracts 114  122)
114.) A Simplified Utilitarian Bile Duct Injury Classification: Based
on Mortality, Financial, and Re-stricture Data.
Ravi Nagubandi, MD, Michael Marvin, MD, Steve Rudich, MD, Ravindra
Kadiyala, MD, Amit Tevar, MD, Michael Nussbaum, MD, Andreas Gelrud,
MD, Jeff Mathews, MD, Tariq Shaqoor, MD, Joseph Buell, MD, Jewish
Hospital, University of Louisville, Louisville, KY; University of Cincinnati,
Cincinnati, OH.
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115.) Carcinoma of the Extrahepatic Bile Ducts: A Comparison of
Proximal and Distal Lesions
Peter J Allen, MD, David Klimstra, MD, Michael D’angelica, MD, Ronald
Dematteo, MD, Yuman Fong, MD, Leslie H Blumgart, MD, Murray F
Brennan, MD, William R Jarnagin, MD, Memorial Sloan-Kettering Cancer
Center, New York, NY.
116.) ‘‘Sideways’’: Results Of Repair Of Biliary Injuries Using A
Policy Of Side-To-Side Hepatico-Jejunostomy (Hj).
Emily R Winslow, MD, Elizabeth A Fialkowski, MD, David C Linehan, MD,
William G Hawkins, MD, Steven M Strasberg, MD, Washington University
School of Medicine, Saint Louis, MO.
117.) Bile duct injuries associated with laparoscopic cholecystect-
omy: timing of repair determines long term outcomes
Simon C Chow, Ajay K Sahajpal, Elijah Dixon, Paul D Greig, David R Grant,
Bryce R Taylor, Mark Cattral, Steve Gallinger, Alice C Wei, Division of General
Surgery, University of Toronto, Toronto, ON, Canada; Mayo Clinic, Rochester,
MN; University of Calgary, Calgary, AB, Canada; Toronto General Hospital,
University Health Network, Toronto, ON, Canada; Mount Sinai Hospital,
Toronto, ON, Canada.
118.) The Influence of Body Mass Index on the Incidence and
Severity of Biliary Infections
Lygia Stewart, MD, J Mcleod Griffiss, MD, Gary A Jarvis, PhD, Lawrence W
Way, MD, UCSF/SF VAMC, San Francisco, CA; UCSF, San Francisco, CA.
119.) Surgical Specialization and Operative Mortality in HPB
Surgery
Nicholas Csikesz, B.Sc., Shimul A Shah, MD, University of Massachusetts,
Worcester, MA.
120.) Impact of tumor extent and lymph node involvement on
survival in gallbladder adenocarcinoma.
Victor Zaydfudim, MD, Irene D. Feurer, PhD, C. Wright Pinson, MD, MBA,
Vanderbilt University Medical Center, Nashville, TN.
121.) Timing of Referral Impacts Surgical Outcomes in Patients
Undergoing Repair of Bile Duct Injuries
Craig P. Fischer, MD, MPH, Bridget N. Fahy, MD, Thomas A. Aloia, MD,
Barbara L. Bass, MD, Weill Medical College of Cornell University, Houston,
TX.
122.) The Obstructed Pancreato-Biliary Limb: Presentation, Man-
agement and Outcomes
David Odell, MD, Wande Pratt, Mark Callery, MD, Charles Vollmer, MD, Beth
Israel Deaconess Medical Center, Boston, MA.
4:45 pm  5:00 pm Refreshment Break
5:00 pm  6:00 pm INVITED VIDEO SESSION 1: PANCREAS
Moderator: Michael Farnell
1. Pancreaticoduodenectomy for cancer: What Constitutes an Adequate
Resection? Michael Farnell
2. Total Pancreatectomy with Islet Autotransplantation  John Christein
3. Transduodenal Resection of Periampullary Tumors  Douglas Tyler
4. Laparoscopic Distal Pancreatectomy  Juan Pekolj
5. Distal pancreatectomy with en bloc celiac axis resection for locally
advanced pancreatic body cancer-Satoshi Kondo
INVITED VIDEO SESSION 2: LIVER
Moderator: Peter Lodge
1. Partial Hepatectomy with Portal Vein Reconstruction  Peter Lodge
2. Principles of Resection for Hilar Cholangiocarcinoma  Jonathan Koea
3. Living Donor Hepatectomy  Amadeo Marcos
4. Laparoscopic Hemi-hepatectomy with Pedicle Ligation  David
Linehan
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NOTE: Abstracts 123 to 134 are in the Competitive Video Session,
March 30, 2008 at 7:15 am
6:00 pm  7:15 pm Oral Poster Session
Oral Posters-Basic Science II
Abstract Numbers 135  144
135.) Liver Regeneration And Recanalization Time-Course Follow-
ing Reversible Portal Vein Embolization
Panagiotis Lainas, MD, Lyes Boudechiche, PhD, Angel Osorio, PhD, Anne
Weber, PhD, Daniele Pariente, MD, Dominique Franco, MD, PhD, Ibrahim
Dagher, MD, PhD, Antoine Beclere Hospital, Clamart, France; INSERM,
Kremlin Bicetre, France.
136.) N-O Donor Drugs Improve Hepatocytes Transplantation In
Mouse Liver
Ibrahim Dagher, MD, PhD, Lyes Boudechiche, PhD, Panagiotis Lainas, MD,
Michelle Hadchouel, MD, PhD, Anne Weber, PhD, Dominique Franco, MD,
PhD, Antoine Beclere Hospital, Clamart, France; INSERM, Kremlin Bicetre,
France.
138.) Steatosis causes impairment of hepatocyte metabolism
Justin D Ellett, B.Sc., Eric R Hall, Ed L Lecluyse, PhD, Kenneth D Chavin,
MD, PhD, Medical University of South Carolina, Charleston, SC; CellzDirect,
Pittsboro, NC.
139.) The Effect of Tissue Inhibitor of Metalloproteinase-3 (TIMP-
3) on TNF-a 945; Levels in Rats undergoing Sub-lethal Total Hepatic
Ischemia
Ari J Cohen, MD, O. Rama Swamy, PhD, Zhenya Tang, MD, PhD, Ian
Carmody, MD, Nigel Girgrath, MD, George Loss, MD, PhD, Ochsner Clinic
Foundation, New Orleans, LA.
140.) Focal Adhesion Kinase is a Key Regulator of Pancreatic
Cancer Cell Migration
Jayme B. Stokes, MD, Paul W. Wright, Jill K. Slack- Davis, PhD, J. Thomas
Parsons, PhD, Todd W. Bauer, MD, University of Virginia, Charlottesville, VA.
141.) Post surgical abdominal wound infection due to Non tuber-
culous rapid growing mycobacteria: Dignosis and management
Vijaya Lakshmi Nag, MD, T N Dhole, MD, Nihar Ranjan Dash, MS, Sanjay
Gandhi Post Graduate Institute Of Medical Sciences, Lucknow, India; All India
Institute Of Medical Sciences, New Delhi, India.
142.) Oxaliplatin Impairs Post-Hepatectomy Liver Regeneration in
a Murine Model
Perry A Soriano, MD, Nian Liu, MD, Erick Castillo, Brock Foster, Avo
Artinyan, MD, Joseph Kim, MD, Wendong Huang, PhD, Lawrence D
Wagman, MD, City of Hope National Medical Center, Duarte, CA.
143.) Relationship between dendritic cells generation from periph-
eral blood mononuclear cells and morbidity and mortality after
pancreatic surgery
Andre S Matheus, MD, PhD, Mariza Treglia, Jose Jukemura, MD, PhD, Jose
Eduardo Monteiro Cunha, Marcel Cerqueira Cesar Machado, MD, PhD, Jose
Alexandre Barbuto, MD, PhD, University of Sao Paulo, Sao Paulo, Brazil.
144.) Opioid Growth Factor mediated inhibition of Hepatic
Carcinoma in vitro
Diego Avella, MD, Luis J Garcia, MD, Hephzibah Tagaram, PhD, Mandeep
Shembey, None, Serene Shereef, MD, Eric Kimchi, MD, Patricia Mclaughlin,
None, Ian Zagon, PhD, Kevin Staveley-o’carroll, MD, PhD, Penn State
University, Hershey, PA.
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Oral Posters  Biliary II
Abstract Numbers 146  154
146.) Surgical treatment and outcome of hilar cholangiocarcinoma
Kazuhiro Otani, MD, PhD, Kazuo Chijiiwa, MD, PhD, Masahiro Kai, MD,
PhD, Motoaki Nagano, MD, Kazuyo Tsuchiya, MD, Kazuhiro Kondo, MD,
PhD, Miyazaki University School of Medicine, Miyazaki, Japan.
147.) An Evaluation Of Novel Electrosurgical Devices In Biliary
Tract Surgery
William W Hope, MD, William L Newcomb, MD, Thomas M Schmelzer,
Jessica J Heath, B.Sc., Amy E Lincourt, PhD, B. Todd Heniford, MD, David A
Iannitti, MD, Carolinas Medical Center, Charlotte, NC.
148.) Endoscopic Microwave Coagulation Is Extremely Effective At
Local Contorol Of Malignant Biliary Obstruction
Ogata Kenji, MD, PhD, Maeshiro Kensei, Yamashita Yuichi, MD, PhD, Ikeda
Seiyo, MD, PhD, fukuoka university school of medicine, Fukuoka, Japan.
149.) Timing Of Operation And Frequency Of Attacks Do Not
Influence Patient Satisfaction 1 Year Following Laparoscopic
Cholecystectomy (LC).
Samaad Malik, MD, MSc, Bruce Reeder, MD, FRCP, Roger Keith, MD,
FRCP, University of Saskatchewan, Saskatoon, SK, Canada.
150.) Biliary Cystadenoma: Case Reports and Review of the
Literature
C K Chang, MD, T M Macpherson, MD, R C Liu, MD, S K Liu, MD, P R
Fuchshuber, MD, PhD, Kaiser Permanente, Walnut Creek, CA.
151.) Mirizzi Syndrome type II-Laparoscopic approach.
Juan Pekolj, Mariano Luis Bregante, MD, Diego Lucas Ferna´ndez, MD, Juan
Antonio Salceda, MD, Victoria Ardiles, MD, Eduardo De Santiban˜es, MD,
Hospital Italiano Buenos Aires, Buenos Aires, Argentina.
152.) Navigation and visualisation in liver surgery-Current status
Lutz Mirow, MD, Philipp Hildebrand, Markus Kleemann, Uwe Roblick, MD,
Hans-peter Bruch, MD, PhD, University Hospital of Schleswig-Holstein,
Lu¨beck, Germany.
153.) Year 2: An Update of a High Volume Non-University Referral
Center Pancreaticoduodenectomy Feasibility Study
Christos A. Galanopoulos, MD, Allison Vo, RN, D. Rohan Jeyarajah, MD,
Methodist Dallas Medical Center, Dallas, TX.
154.) Trends in the Regionalization of Pancreatic Resection
Procedures to High-Volume Providers
John E Scarborough, MD, Ricardo Pietrobon, MD, PhD, Rebekay R White,
MD, Bryan M Clary, MD, Douglas S Tyler, MD, Theodore N Pappas, MD,
Duke University School of Medicine, Durham, NC.
Oral Posters  Liver III
Abstract Numbers 155  164
155.) Magnetic Resonance Imaging is a powerful tool for charac-
terizing the impact of Radiofrequency Ablation in a Murine model
of Spontaneous Hepatocellular Cancer
Serene Shereef, Diego Avella, MD, Luis Garcia, MD, Hephzibah Rani S
Tagaram, PhD, Nihraj Gusani, MD, Mehrdad Nikfarjam, MD, Eric Kimchi,
MD, Kevin Staveley-o’carroll, MD, PhD, Penn State Milton S Hershey Medical
Center, Hershey, PA.
156.) Histological evaluation of liver recovery after radiofrequency
ablation-assisted resection
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Peng Yao, PhD, Javed Akhter, PhD, David Lawson Morris, MD, PhD,
University of New South Wales, Sydney, Australia.
157.) A randomised controlled study of the efficacy of fibrin glue in
reducing fluid collections following liver surgery
Peng Yao, Francis Chu, MBBS, David Lawson Morris, MD, PhD, University of
New South Wales, Sydney, Australia.
158.) Continuous Hemofiltration of Hepatic Venous Effluent Allows
Regional Delivery of High-Dose Melphalan via a Minimally Invasive
Approach
Edmund Bartlett, Erin R Gardner, Richard E Royal, MD, Udai S Kammula,
MD, William D Figg Sr, PharmD, James F Pingpank Jr, MD, Surgery Branch,
NCI, NIH, Bethesda, MD; Clinical Pharmacokinetics Section, NCI, NIH,
Bethesda, MD.
159.) Implementation of a Multidisciplinary Treatment Team for
Hepatocellular Cancer at a Veterans Affairs Medical Center
Improves Survival
Tammy T. Chang, MD, PhD, Rajiv Sawhney, MD, Alexander Monto, MD, J.
Ben Davoren, MD, PhD, Jacob G. Kirkland, Lygia Stewart, MD, Carlos U.
Corvera, MD, University of California, San Francisco, San Francisco, CA.
160.) Is The Early Recurrence Related With Survival After Surgical
Resection Of Hepatocellular Carcinoma?
Andrea Ruzzenente, Calogero Iacono, Silvia Pachera, Paola Nicoli, Monica
Fontana, Alfredo Guglielmi, University of Verona, Verona, Italy.
161.) A Novel Technique for RadioFrequency Ablation of Hepatic
Dome Neoplasms Using Iatrogenic Hydrothorax.
Francis E Rosato Jr, MD, Lawrence Needleman, MD, Ernest L Rosato, MD,
Thomas Jefferson Univeristy, Philadelphia, PA.
162.) Hepatic Adenoma in Pregnancy, Resection versus Observation
Nabil N. Dagher, MD, Juan D Arenas, MD, UT Southwestern Medical Center,
Dallas, TX.
163.) Is There A Role for Aggressive Hepatic Resection in Metastatic
Ovarian Carcinoma?
S Rudich, MD, PhD, T Doty, RN, J Basil, MD, H Schellhas, MD, A Marshall,
RN, J Buell, MD, A Tevar, MD, E S Woodle, MD, Univ of Cincinnati Med Ctr,
Cincinnati, OH; Good Samaritan Hospital, Cincinnati, OH.
164.) Use of InLine Multichannel Radiofrequency Device reduces
blood loss and the need for portal triad clamping during hepatec-
tomies.
Hamed Kargozaran, MD, Amrik Singh, MD, Laurel Beckett, PhD, Yueju Li,
MS, Stephen Wilkendorf, None, Vijay P Khatri, MD, university of california
Davis medical center, Sacramento, CA.
Oral Posters  Liver/Transplant
Abstract Numbers 165  174
165.) Hepatic Resection for Cholangiocarcinoma in Elderly Patients
George Collis, MD, John Stauffer, MD, Marjorie Dougherty, MS, PA-C, George
Kim, MD, Denise Harnois, DO, Justin H Nguyen, MD, Mayo Clinic,
Jacksonville, FL.
166.) The Hepatic Research Registry; the four year experience
Eric R Hall, Kristen E Mcginty, MPH, Heather A Rollins, Ed L. Lecluyse, PhD,
CellzDirect, Inc, Pittsboro, NC.
167.) The risk of Major Liver resection for colorectal liver
metastases after a chemotherapy associated with bevacizumab is
increased A prospective study of 23 patients
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Be´atrice Aussilhou, MD, Safi Dokmak, MD, Sandrine Faivre, MD, Olivier
Farges, MD, PhD, Catherine Paugam, MD, Vale´rie Paradis, MD, Jacques
Belghiti, MD, Hospital Beaujon, Clichy, France.
168.) Lack of Improved Outcomes for Acetaminophen (APAP)-
Induced Acute Liver Failure (ALF) for Orthotopic Liver Trans-
plantation (OLT) from 1995  2004
Rebecca Y Tam-Bensler, PharmD, John M Vierling, MD, Natasha S Becker,
MD, Christine A O’Mahony, MD, Norman L Sussman, MD, John A Goss,
MD, Rise J Stribling, MD, St. Luke’s Episcopal Hospital, Houston, TX; Baylor
College of Medicine, Houston, TX.
170.) Liver transplantation and pancreatic resection
John Stauffer, MD, Hugo Bonatti, MD, Marjorie Dougherty, PA-C, MPH,
Hannes Goegele, MD, Ronald Hinder, MD, PhD, Jaime Aranda-michel, MD,
Rolland C Dickson, MD, Timothy Schmitt, MD, Denise Harnois, DO, Justin
Nguyen, MD, Mayo Clinic, Jacksonville, FL; UVA, Charlottesville, VA.
171.) Glutathione And Albumin Turn-Over In Human Livers In
Normal And Disease & Transplanted Grafts. Preliminary Results.
Juan R Sanabria, ScD, MD, Rime Abbas, MD, H Kombo, PhD, V Anderson,
PhD, Steve Pravis, PhD, Henry Brunengraber, MD, PhD, University Hospitals-
Case Medical Center, Cleveland, OH; Case Western Reserve University,
Cleveland, OH.
172.) The Role of Liver Transplantation for Hepatic Adenomatosis
in the Pediatric population: Case Report and Review of the
literature
Jason R Wellen, MD, Christopher D. Anderson, MD, M. B. Majella Doyle, MD,
Surendra Shenoy, MD, PhD, William C Chapman, MD, Jeffrey A Lowell, MD,
Washington University, St. Louis, MO.
173.) Histologic Findings in Post-reperfusion and Follow-up biop-
sies in Liver Transplant Patients: Is There Any Correlation?
Mohammad Raoufi, MD, Chan Ma, MD, Adrian Ormsby, MD, Veena Shah,
MD, Kimberly Brown, MD, Mary Ann Sherbondy, MD, Dilip Moonka, MD,
Marwan Abouljoud, MD, Henry Ford Hospital, Detroit, MI.
174.) Complications of percutaneous liver biopsy following liver
transplantation
Timothy Schmitt, MD, Hugo Bonatti, MD, Charles Jeanpierre, MD, John
Stauffer, MD, Rolland C Dickson, Justin Nguyen, MD, Denise Harnois, DO,
Jaime Aranda-michel, MD, UVA, Charlottesville, VA; Mayo Clinic, Jackson-
ville, FL; Mayo Clinic, Jacksonville, VA.
Oral Posters  Liver IV
Abstract Numbers 175  184
175.) Selective Internal Radiation Therapy for Advanced Hepato-
cellular Carcinoma: Is There a Benefit?
S Rudich, MD, PhD, C Schatzman, RN, A Tevar, MD, J Buell, MD, E S
Woodle, MD, T Doty, RN, A Marshall, RN, R Ristagno, MD, D Zuckerman,
MD, Univ of Cincinnati Med Ctr, Cincinnati, OH.
176.) Liver transplantation surgical principles in the management of
extensive retroperitoneal tumors.
Manoj K Singh, MD, Caroline Rochon, MD, Juan P Rocca, MD, Patricia A
Sheiner, MD, Manuel I Rodriguez Davalos, MD, Majid Eshghi, MD, David M
Schwalb, MD, Muhammad Choudhury, MD, Marcelo E Facciuto, MD,
Westchester Medical Center, New York Medical College, Valhalla, NY.
177.) Laparoscopic Liver Resections: Initial Experience
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Juan Pekolj, MD, Diego Lucas Ferna´ndez, MD, Mariano Luis Bregrante, MD,
Juan Antonio Salceda, MD, Eduardo De Santibann˜es, MD, Rodrigo Sanchez
Claria´, MD, Hospital Italiano Buenos Aires, Buenos Aires, Argentina.
178.) Radical Surgical Management For Hepatic Hydatid Cysts In
An Hpb Center From Argentina
Javier C Lendoire, MD, Fernando Duek, Pablo Barros Schelotto, MD, Carlos
Quarin, MD, Gabriel Raffin, MD, Vero´nica Garay, MD, Oscar Imventarza,
MD, Hospital Dr Cosme Argerich, Buenos Aires, Argentina.
179.) Chemotherapy and Selective Internal Radiation Treatment
with Y-90 Microspheres (Chemo-SIRT) Improves Objective Re-
sponses in Patients with Colorectal Cancer Liver Metastases
Compared to Chemotherapy Alone
Seza A Gulec, MD, Richard Hostetter, MD, Geraldine Mesoloras, MS, Thomas
Fischbach, MD, Daniel Bruetman, MD, Kenneth Pennington, MD, Center for
Cancer Care at Goshen Health System, Goshen, IN.
180.) Staged Liver Resection for Extensive Bilobar Colorectal Liver
Metastases
Peter Metrakos, MD, Amy Neville, MD, Mazen Hassanain, MD, Gabriel
Chan, MD, Nicholas Meti, Dionisios Vrochides, MD, Prosanto Chaudhury,
MD, McGill University, Montreal, QC, Canada.
181.) Laparoscopic Liver Resection: Distribution of Complications
Ravi Nagubandi, MD, Kadiyala V Ravindra, MD, Mark Thomas, MD,
Michael Marvin, MD, Steve Rudich, MD, Amit Tevar, MD, Joseph Buell, MD,
Jewish Hospital, University of Louisville, Louisville, KY, Louisville, KY; Jewish
Hospital, University of Louisville, Louisville, KY; University of Cincinnati,
Cincinnati, OH.
182.) Multi-modality therapy of hepatic neuroendocrine metastases
Matthew H Katz, MD, James Yao, MD, Daniel Anaya, MD, Steven Curley,
MD, Eddie K Abdalla, MD, Jean-nicolas Vauthey, MD, MD Anderson Cancer
Center, Houston, TX.
183.) Hepatic hydatidosis successfully managed with PAIR (Percu-
taneous Aspiration, Injection, and Reaspiration).
William Scott Helton, MD, Christine Donaldson, MD, MPH, Marco Fischela,
MD, hospital of Saint Raphael, New Haven, CT; university of illinois at chicago,
Chicago, IL; University of California San Francisco, San Francisco, CA.
184.) Evaluation of hemostatic factors in patients undergoing major
hepatic resection and Whipple procedures
Juan M Sarmiento, MD, Fania Szlam, MD, Kenichi Tanaka, MD, Jerrold H
Levy, MD, Emory University, Atlanta, GA.
Oral Posters  Liver/Pancreas
Abstract Numbers 185  194
185.) Surgical Management of Hepatic Endometriosis: a rare liver
lesion
Nicole P Bernal, MD, Kian Modanlou, MD, Saint Louis University Hospital,
Saint Louis, MO.
186.) Percutaneous versus Open/Laparoscopic Radiofrequency
Ablation: Is there a difference?
Evan S Ong, MD, Mohamed A Alassas, MD, Alan Litwan, MD, Peter Loud,
MD, John Gibbs, MD, Boris Kuvshinoff, MD, Roswell Park Cancer Institute,
Buffalo, NY.
187.) Radiofrequency Coagulation in Laparoscopic Liver Resection:
Evaluation of a Novel Laparoscopic Device.
Ravi Nagubandi, MD, Kadiyala Ravindra, MD, Michael Marvin, MD, Mark
Thomas, MD, Steve Rudich, MD, Amit Tevar, MD, Joseph Buell, MD, Jewish
Hospital, University of Louisville, Louisville, KY; University of Cincinnati,
Cincinnati, OH.
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189.) Mesh reinforcement of a stapled pancreatic transection line
reduces the rate of leak
Fabian Johnston, MD, Antonino Cavataio, Nicholas Hamilton, MD, Peter
Simon, MD, Brent Mathews, MD, Michael Brunt, MD, Christopher Eagon,
MD, David Linehan, MD, Steven Strasberg, MD, William Hawkins, MD,
Washington University in St. Louis, St. Louis, MO.
190.) Braun enteroenterostomy is associated with reduced delayed
gastric emptying and early resumption of oral feeding following
pancreaticoduodenectomy
Steven N Hochwald, MD, Stephen R Grobmyer, MD, Eleanor Curran, PA-C,
MPH, David A Bloom, PhD, Matthew Delano, MD, Alan W Hemming, MD,
Kevin E Behrns, MD, Stephen B Vogel, MD, University of Florida College of
Medicine, Gainesville, FL.
191.) Hepatic Resection With Pancreatoduodenectomy: Be Aware
Of The Pancreas
Emmanuel Melloul, MD, Mircea Chirica, MD, Re´za A Kianmanesh, MD,
Alain Sauvanet, MD, Jacques Belghiti, MD, Hospital Beaujon, Clichy, France.
192.) Non-Dysplastic Mucinous Cysts (NDMC) of the Pancreas
Patrick Ross, MD, Charles Vollmer, MD, Jeffrey Goldsmith, MD, Ivan Pedrosa,
MD, Mandeep Sawhney, MD, Alphonso Brown, MD, Mark Callery, MD, Beth
Israel Deaconess Medical Center, Boston, MA.
194.) Surgical Margin, Lymph-Node Status, Tumor Differentiation,
Uicc Stage And Adjuvant Therapy Are Relevant Prognostic Factors
After Resection In Pancreatic Cancer
Calogero Iacono, MD, Andrea Ruzzenente, Chiara Zugni, Tommaso Campag-
naro, Luca Bortolasi, Alessandro Valdegamberi, Alfredo Guglielmi, University of
Verona, Verona, Italy.
Oral Posters  Pancreas III
Abstract Numbers 195  203
195.) A Novel use of On Q Pain Pumps during Pancreaticoduode-
nectomy: Celiac Ganglia Placement
Christos A. Galanopoulos, MD, Gong A. Lee, MD, Girish P. Joshi, MD, D.
Rohan Jeyarajah, MD, Methodist Dallas Medical Center, Dallas, TX;
University of Texas-Sowthwest, Dallas, TX.
196.) Pattern of Recurrence after Pancreatoduodenectomy with
Standard Versus Extended Lymphadenectomy for Pancreatic Head
Adenocarcinoma
Thomas Schnelldorfer, MD, Michael G. Sarr, MD, Tamela R. Dahl, RN,
Nathan R. Foster, MS, Randall K. Pearson, MD, Suresh T. Chari, MD,
Michael B. Farnell, MD, Mayo Clinic, Rochester, MN.
197.) Portal venous recollateralization after a pancreaticoduode-
nectomy
Justin H Nguyen, Marjorie Dougherty, MS, PA-C, Mayo Clinic, Jacksonville,
FL.
198.) Tumor Location Determines Survival in Pancreatic Cancer
Avo Artinyan, MD, Perry A Soriano, MD, Tracey Low, Joshua D Ellenhorn,
MD, Joseph Kim, MD, City of Hope National Medical Center, Duarte, CA.
199.) Endoscopic kysto-gastrostomy using an expandable metallic
Wallstent as salvage of a failed endoscopic drainage of pancreatic
pseudocysts: report of 2 cases.
Franck Vandenbroucke, MD, Marylene Plasse, MD, Richard Letourneau, MD,
Michel Dagenais, MD, Real Lapointe, MD, Andre Roy, Hopital Saint Luc-
CHUM, Montreal, PQ, Canada.
200.) Extended Left-Sided Pancreatectomy with Spleen Preserva-
tion
Arash Mohebati, MD, Roderich E Schwarz, MD, UMDNJ-RWJMS, New
Brunswick, NJ; UT Southwestern Medical Center, Dallas, TX.
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201.) Assessment of delayed gastric emptying following classical as
well as pylorus preserving pancreaticoduodenectomy: Solid state
scintigrafic scan or clinical criteria or both?
Nihar R Dash, MS, Ghatak Supriyo, MS, Mukund Kulkarni, MS, Sujoy Pal,
MS, Peush Sahni, MS, Tushar Kanti Chattopadhyay, MS, All India Institute
Of Medical Sciences, New Delhi, India.
202.) Intraoperative Radiation Therapy (IORT) Improves Local
Control But Does Not Impact Survival in Patients Undergoing
Pancreaticoduodenectomy (PD) for Pancreatic Adenocarcinoma-a
Case-Control Series.
Adam C Berger, MD, Atul Rao, MD, Pramila Rani Anne, MD, Cataldo Doria,
MD, Francis E. Rosato Sr., MD, Ernest L Rosato, MD, Thomas Jefferson
University, Philadelphia, PA.
203.) Survival after Pancreaticoduodenectomy for Pancreatic
Adenocarcinoma vs. Distal Cholangiocarcinoma Is Equivalent,
Independent of Stage and Staging Schemes
John Mullinax, MD, Desiree Villadolid, MPH, Jonathan Hernandez, MD,
Kevin Drummond, None, Nasreen Vohra, MD, Steven Goldin, MD, PhD,
Alexander Rosemurgy, MD, University of South Florida College of Medicine
Department of Surgery, Tampa, FL.
7:30 pm  9:00 pm Glow in the Dark Beach Volleyball
Sunday March 30, 2008
7:15 am  9:15 am Competitive Video Session 1 and 2
Competitive Video Session 1: Pancreas Abstracts 123128a
123.) Laparoscopic Spleen-Preserving Total Pancreatectomy For
Multifocal Ipmn
Michael L Kendrick, MD, Mayo Clinic, Rochester, MN.
124.) Laparoscopic Distal Pancreatectomy with Splenic Preserva-
tion
Richard A Mackey, MD, R. Matthew Walsh, MD, St. Joseph Medical Center,
Towson, MD; Cleveland Clinic, Cleveland, OH.
125.) Central Pancreatectomy with Pancreaticogastrostomy for
Mucinous Cystadenoma of the Pancreatic Neck
David A Kooby, MD, Emory University, Atlanta, GA.
126.) Pancreatogenous Adult Hyperinsulinemic Hypoglucemia
Syndrome
Juan Pekolj, MD, Diego Lucas Ferna´ndez, MD, Juan Antonio Salceda, MD,
Mariano Bregante, MD, Eduardo De Santibann˜es, MD, Hospital Italiano
Buenos Aires, Buenos Aires, Argentina.
*Abstract 127 below will be presented on Saturday afternoon in the
INVITED VIDEO SESSION 1: PANCREAS from 5:00  6:00 pm due
to travel arrangements
*127.) Distal pancreatectomy with en bloc celiac axis resection for
locally advanced pancreatic body cancer
Satoshi Kondo, MD, Satoshi Hirano, MD, Eiichi Tanaka, MD, Toshiaki
Shichinohe, MD, On Suzuki, MD, Hokkaido University Graduate School of
Medicine, Sapporo, Japan.
128.) Laparoscopic Distal Pancreatectomy and Splenectomy
Alexander Rosemurgy, MD, Harold Paul, None, Desiree Villadolid, MPH,
Mark Shaprio, B.Sc., Sharona B. Ross, MD, Donovan Tapper, MD, Sarah M
Cowgill, MD, University of South Florida College of Medicine Department of
Surgery, Tampa, FL.
128a.) Duodenal Gastro Intestinal Stromal Tumor. Laparoscopic
Treatment.
Sergio E Bustos, MD, Jorge Eduardo Nefa, MD, Pablo Esteban Omelanczuk,
MD, Italian Hospital of Mendoza, Mendoza, Argentina.
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Competitive Video Session 2: Liver Abstracts 129  134a
129.) Totally Laparoscopic Central Hepatectomy
Andrew A Gumbs, Brice Gayet, MD, PhD, Columbia University College of
Physicians and Surgeons, New York, NY; Institut Mutualiste Montsouris, Paris,
France.
130.) Totally Laparoscopic Extended Left Hepatectomy
Andrew A Gumbs, Barak Bar-zakai, MD, Brice Gayet, MD, PhD, Columbia
University College of Physicians and Surgeons, New York, NY; Institut
Mutualiste Montsouris, Paris, France.
131.) Use of the radiofrequency ablation device (Habib -4X;) in
laparoscopic hepatic parenchymal transection.
Alejandro Mejia, MD, Stephen Cheng, MD, Liver Institute at Methodist Dallas,
Dallas, TX.
132.) Laparoscopic, Robotic-assisted Completion Cholecystectomy
John B Martinie, Juan Carlos Vasquez, MD, Geoffrey P. Kohn, MD, University
of North Carolina, Chapel Hill, NC.
133.) Open left hemihepatectomy for colorectal metastases utilizing
the Gyrus Open Forceps for parenchymal transection
Matthew R Porembka, MD, William G Hawkins, MD, Washington University
in St Louis, Saint Louis, MO.
134.) Kassabach-Merritt Syndrome Due To Giant Liver Haeman-
gioma Techniques For Haemostasia And Vascular Control.
Eduardo De Santiban˜es, MD, Juan Pekolj, MD, Juan Antonio Salceda, MD,
Rodrigo Sanchez Claria, MD, Diego Lucas Fernandez, MD, Mariano Luis
Bregante, MD, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
134a.) Robotic Left Lateral Segment Resection
Marwan Abouljoud, Henry Ford Hospital, Detroit, MI
9:15 am  11:15 am Free Papers Potpourri Abstracts 204  210
204.) Hepato-Pancreato-Biliary Surgery: Effect of Surgical Case-
mix on Peri-Operative Mortality
Hari Nathan, MD, Michael Choti, MD, Richard D Schulick, MD, Timothy M
Pawlik, MD, Johns Hopkins, Baltimore, MD.
205.) Accurate radiological diagnosis of microinvasion of portal vein
in hepatocellular carcinoma by distortion of the corona enhance-
ment, tumoral arterioportal shunt and perilesional hyperintense
rim
Ryohei Miyata, MD, Akihiro Tanimoto, MD, Go Wakabayashi, MD, Masaki
Kitajima, MD, Tokyo Dental College, Chiba, Japan; Keio University, Shinjuku
Tokyo, Japan.
206.) Outcomes Associated with Cytoreductive Surgery and In-
traperitoneal Hyperthermic Chemotherapy for Colorectal Cancer
Patients with Peritoneal Carcinomatosis and Hepatic Metastases
Oliver A Varban, MD, Edward A. Levine, MD, John H. Stewart, MD, Thomas
Mccoy, MS, Perry Shen, MD, Wake Forest University Medical Center, Winston-
salem, NC.
207.) Societal reintegration and Economic implications following
orthotopic liver transplant
Michele Molinari, MD, Amy Gillis, MD, Mark Joseph Walsh, MD, Dalhousie
University, Halifax, NS, Canada.
208.) Outcomes in Pancreatic Resection are Negatively Influenced
by Preoperative Hospitalization
Wande Pratt, Charles Vollmer, MD, Mark Callery, MD, Beth Israel Deaconess
Medical Center, Boston, MA.
209.) Prospective Evaluation Of 65 Pancreatic Cysts-Magnetic
Ressonance Difusion Imaging As A Tool To Differentiate Mucinous
Cysts
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Vladimir Schraibman, MD, Alberto Goldenberg, MD, Suzan M Goldman, MD,
Jacob Szjenfeld, MD, Edson Lobo, MD, Thiago Abud, MD, Federal University
of Sao Paulo, Sao Paulo, Brazil.
210.) New Abdominal Intraoperative Ultrasound Phantom Repla-
cing the Animal Lab to Teach Surgeons
Leo Villegas, MD, Junji Machi, MD, Maurice Arregui, MD, Takayuki Ohara,
Toshi Takayama, Hidenobu Katayama, University of Missouri Kansas City,
Kansas City, MO; n/a, Honolulu, HI; n/a, Indianapolis, IN; Kyoto Kagaku,
Torrance, CA.
9:15 am  11:15 am Free Papers Liver Abstracts 211  217
211.) High Dose Intra-Arterial Melphalan Delivered via Percuta-
neous Hepatic Perfusion (PHP) for Patients with Unresectable
Hepatic Metastases from Primary Neuroendocrine Tumors
James F Pingpank Jr, MD, Richard E Royal, MD, Udai S Kammula, MD,
Anthony W Kam, MD, Bradford J Wood, MD, H. Richard Alexander Jr, MD,
Steven K Libutti, MD, Marybeth S Hughes, MD, Susan E Ohl, RN, BSN,
Surgery Branch, NCI, NIH, Bethesda, MD; Diagnostic Radiology Division,
CCR, NCI, NIH, Bethesda, MD; Department of Surgery, University of
Maryland, Baltimore, MD.
212.) A Comparative Analysis of Crush/Clamp, Stapler, and
Dissecting Sealer Hepatic Transection Methods
Eric T Castaldo, MD, MPH, T. Mark Earl, MD, Irene D Feurer, PhD, C.
Wright Pinson, MD, MBA, Vanderbilt University, Nashville, TN.
213.) The Survival Paradox of Elderly Patients after Major Liver
Resections
Alexander J.c. Ijtsma, MD, Liselotte M.s. Boeve´, Christian S. Van Der Hilst,
B.Sc., Marieke T. De Boer, MD, Koert P. De Jong, MD, PhD, Paul M.j.g.
Peeters, MD, PhD, Annet S.h. Gouw, MD, PhD, Robert J. Porte, MD, PhD,
Maarten J.h. Slooff, MD, PhD, University Medical Center Groningen,
Groningen, The Netherlands.
214.) Elevated Preoperative Neutrophil to Lymphocyte Ratio
Predicts Survival Following Hepatic Resection for Colorectal Liver
Metastases.
Karim J Halazun, Amer Aldoori, MD, Hassan Z Malik, MD, Ahmed Al-
mukhtar, MD, K Rajendra Prasad, MD, Giles J Toogood, MD, Giles J Toogood,
MD, Peter A Lodge, MD, St. James’ University Hospital, Leeds UK, Leeds,
United Kingdom.
215.) Laparoscopic Liver Resection With Prior Vascular Control
Ibrahim Dagher, MD, PhD, Hadrien Tranchart, MD, Panagiotis Lainas, MD,
Alessio Carloni, MD, Dominique Franco, MD, PhD, Antoine Beclere Hospital,
Clamart, France.
216.) Circulating Tumor Cells in Patients Undergoing Surgery for
Hepatic Metastases from Colorectal Cancer
Pavlos Papavasiliou, MD, Joseph Kuhn, MD, John Nemunaitis, MD, Jeffrey
Lamont, MD, Baylor University Medical Center, Dallas, TX; Mary Crowley
Cancer Research Center, Dallas, TX.
217.) Does surgical technique affect recurrence and survival in
patients undergoing resection of colorectal liver metastases?
Anthony Bonavia, B.Sc., Umut Sarpel, MD, Alexis Grucela, MD, Sasan
Roayaie, MD, Myron E. Schwartz, MD, Daniel M. Labow, MD, Mount Sinai
School of Medicine, Ny, NY.
11:15 am  11:30 am Closing Address: Mark Callery, AHPBA President
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